NCT04424381View on ClinicalTrials.gov

Pharmacokinetics and Bioequivalence of Rivaroxaban Tablet in Healthy Chinese Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 4, 2019

Primary Completion Date

September 5, 2019

Study Completion Date

September 20, 2019

Conditions
Healthy Subjects
Interventions
DRUG

Rivaroxaban 20 MG Oral Tablet [Xarelto]

The subjects randomly received single oral administration of Rivaroxaban 20 MG Oral Tablet \[Xarelto\].

DRUG

Rivaroxaban 20 MG Oral Tablet

The subjects randomly received single oral administration of Rivaroxaban 20 MG Oral Tablet.

Trial Locations (1)

266003

Phase I Clinical Research Center, Qingdao

All Listed Sponsors
lead

The Affiliated Hospital of Qingdao University

OTHER

NCT04424381 - Pharmacokinetics and Bioequivalence of Rivaroxaban Tablet in Healthy Chinese Volunteers | Biotech Hunter | Biotech Hunter